Arterial compliance: is it reduced in antiphospholipid syndrome?

Journal of Human Hypertension
T ReitblatS Oren

Abstract

To assess vascular compliance in patients with antiphospholipid syndrome (APS), or antiphospholipid antibodies (aPLs) positivity in comparison to healthy people and diabetes mellitus patients. Twenty-five patients with APS or aPLs, 33 healthy people (HP), 28 patients with diabetes mellitus (DM) underwent pulse wave analysis. Data calculated included the small artery elasticity (SAE), large artery elasticity (LAE) and systemic vascular resistance (SVR). Statistical analysis was performed as appropriate. The patient group was divided into two subgroups: APS-1 with warfarin treatment, and APS-2 without warfarin treatment. All patients and healthy subjects were matched by gender, body mass index and lipid profiles. Patients in APS-1 group were significantly younger in comparison to three other groups. After the adjustment for age, we found that SAE in APS-1 group did not differ from SAE in the HP group (6.4+/-1.8 ml/mmHg x 100 and 5.54+/-3.4 ml/mmHg x 100, respectively, P>0.05). In contrast, SAE in the group APS-2 was significantly lower (3.41+/-1.2 ml/mmHg x 100) than in the APS-1 and was almost equal to SAE in the DM group (4.2+/-2.37 ml/mmHg x 100). The SAE in the APS-2, DM and HP groups was inversely correlated with age, wherea...Continue Reading

References

Nov 10, 1989·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·R OmdalW Hinderaker
May 29, 1987·The American Journal of Cardiology·P W WilsonW B Kannel
Feb 1, 1985·The American Journal of Cardiology·S M FinkelsteinW J Shelley
Dec 1, 1993·Journal of the American College of Cardiology·P S SabaR B Devereux
Nov 25, 1997·American Journal of Hypertension·S P GlasserJ N Cohn
Dec 31, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·R WuA K Lefvert
Sep 12, 2003·Current Rheumatology Reports·Joan T Merrill
Mar 30, 2005·Scandinavian Journal of Rheumatology·I MaraiY Shoenfeld

❮ Previous
Next ❯

Citations

Jun 29, 2010·Metabolism: Clinical and Experimental·Teemu KoivistoinenMika Kähönen
Jan 1, 2008·Expert Review of Clinical Immunology·Paul R J AmesAnnamaria Margarita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.